Business

New Jersey journalist talks about CBS2’s experience in participating in the Moderna COVID-19 vaccine trial – CBS New York

New York (CBSNewYork) — As the number of cases of coronavirus increases nationwide, the second COVID-19 vaccine has a new breakthrough.

Alice Gainer of CBS2 spoke with a local woman who attended the trial as hospitals across the country continue to be under pressure.

In El Paso, Texas, prisoners loaded their bodies on morgue trucks. In Utah, hospitals are pushed to the limit.

Nevertheless, some COVID-19 patients are still suspicious of their diagnosis.

Nurses in South Dakota often see it.

“Their last dying word is,’This can’t happen. It’s not true.’ And when you need to spend time on your family’s Face Timing, they’re full of anger and hatred,” Jodi Doering said. Mr. says.

Coronavirus pandemic

The number of COVID-19 cases exceeded 11 million in the United States over the weekend, including the one million recorded last week.

At least 27 states impose new coronavirus restrictions on businesses and rallies. California is one of them.

“Currently, 40 counties are retreating in the state,” said Governor Gavin Newsom.

In nearby Philadelphia, new restrictions will apply on Friday. Eating indoors is prohibited. The gym, library and museum will also be closed.

“The average number of positive COVID-19 cases reported per day in Philadelphia surged by at least 700% in less than two months,” said Mayor Jim Kenny.

However, there was a bright spot on Monday. In a study of 30,000 participants, scientists found that the Moderna vaccine was nearly 95% effective. Dr. Anthony Fauci’s team at the National Institutes of Health worked with Moderna.

“With such a respiratory virus vaccine, and as a new virus, nearly 95% efficacy is really a significant achievement,” Fauci said.

More: Biden warns of “very dark winter”, emphasizing the need for coronavirus relief

Lindy Washburn, a local New Jersey journalist, was part of the vaccine trial.

“People said,’Wow, thank you for doing this.'” They say, “I never do this, but I’m glad you did. Thank you very much.’ So I’m happy to do that, “said Washburn.

Washburn, who works at NorthJersey.com and USA Today Network, was urged to sign up after writing a story about the trial.

“This is how we make progress. To advance science, people need to participate in clinical trials,” says Washburn.

She said she wasn’t sure if she had been vaccinated, but she had few side effects when she was vaccinated and urged others to get it if approved.

Moderna’s results follow last week’s announcement that Pfizer’s vaccine is more than 90% effective. Both companies expect to have doses available to high-risk individuals by the end of the year.

More from CBS New York

You can get the latest news, sports and weather with our brand new CBS New York app. Download from here.

New Jersey journalist talks about CBS2’s experience in participating in the Moderna COVID-19 vaccine trial – CBS New York

Source link New Jersey journalist talks about CBS2’s experience in participating in the Moderna COVID-19 vaccine trial – CBS New York

Back to top button